Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) Gross Margin (2020 - 2025)

Historic Gross Margin for Biofrontera (BFRIW) over the last 6 years, with Q3 2025 value amounting to 70.74%.

  • Biofrontera's Gross Margin rose 248500.0% to 70.74% in Q3 2025 from the same period last year, while for Sep 2025 it was 64.41%, marking a year-over-year decrease of 17100.0%. This contributed to the annual value of 50.14% for FY2024, which is 13400.0% up from last year.
  • Biofrontera's Gross Margin amounted to 70.74% in Q3 2025, which was up 248500.0% from 70.74% recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Gross Margin peaked at 112.8% during Q4 2023, and registered a low of 77.84% during Q2 2023.
  • Moreover, its 5-year median value for Gross Margin was 70.74% (2025), whereas its average is 59.81%.
  • Over the last 5 years, Biofrontera's Gross Margin had its largest YoY gain of 1850700bps in 2023, and its largest YoY loss of -1744300bps in 2023.
  • Biofrontera's Gross Margin (Quarter) stood at 98.03% in 2021, then tumbled by -174bps to 72.27% in 2022, then soared by 256bps to 112.8% in 2023, then tumbled by -49bps to 58.03% in 2024, then rose by 22bps to 70.74% in 2025.
  • Its last three reported values are 70.74% in Q3 2025, 70.74% for Q2 2025, and 61.95% during Q1 2025.